OPG was shown to inhibit the development of osteolytic bone disease in MM.(19) In general, an increase in the RANKL/OPG ratio favors bone destruction.(20, 21) This is seen in inflammatory diseases such as rheumatoid arthritis and in several types of cancers. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.